Although several studies have investigated diverse biomarkers or clinical factors to predict BCR, there are no recognized molecular subtypes and prognostic signature related to BCR for PCa (Arora and Barbieri, 2018). The gene discussed is BCR; the disease is posterior cortical atrophy.